A5063867474- Transplantation: Methods and Outcomes
- Viral Infections and Immunology Research
- Heart Failure Treatment and Management
- Cardiac Health and Mental Health
- Cardiac Structural Anomalies and Repair
- Mechanical Circulatory Support Devices
- Cardiovascular and exercise physiology
- Pneumocystis jirovecii pneumonia detection and treatment
- Renal Transplantation Outcomes and Treatments
- Heart Rate Variability and Autonomic Control
- Organ and Tissue Transplantation Research
- Cardiac pacing and defibrillation studies
- COVID-19 Clinical Research Studies
- Cardiovascular Issues in Pregnancy
- Pulmonary Hypertension Research and Treatments
- Thyroid Disorders and Treatments
- Ion channel regulation and function
- Cardiovascular Effects of Exercise
- Bone health and treatments
- Obstructive Sleep Apnea Research
- SARS-CoV-2 and COVID-19 Research
- Hepatitis C virus research
- Cardiovascular Function and Risk Factors
- Blood Pressure and Hypertension Studies
- Stuttering Research and Treatment
Federal Almazov North-West Medical Research Centre
2017-2024
Institute of Experimental Cardiology
2024
Ministry of Health of the Russian Federation
2018-2023
Secondary prevention through comprehensive cardiac rehabilitation has been recognized as the most cost-effective intervention to ensure favourable outcomes across a wide spectrum of cardiovascular disease, reducing mortality, morbidity and disability, increase quality life. The delivery 'modern' programme is mandatory both in residential out-patient setting expected outcomes. present position paper aims update practical recommendations on core components goals different conditions, order...
A proper determination of the exercise intensity is important for rehabilitation patients with cardiovascular disease (CVD) since it affects effectiveness and medical safety training. In 2013, European Association Preventive Cardiology (EAPC), together American Cardiovascular Pulmonary Rehabilitation Canadian Cardiac Rehabilitation, published a position statement on aerobic assessment prescription in (CR). Since this publication, many subsequent papers were concerning CR, which some...
A key factor to successful secondary prevention of cardiovascular disease (CVD) is optimal patient adherence treatment. However, unsatisfactory rates treatment for CVD risk factors and have been observed consistently over the last few decades. Hence, achieving lifestyle measures guideline-directed medical therapy in rehabilitation a great challenge many healthcare professionals. Therefore, this European Association Preventive Cardiology clinical consensus document, modern reappraisal...
Abstract This Delphi consensus by 28 experts from the European Association of Preventive Cardiology (EAPC) provides initial recommendations on how cardiovascular rehabilitation (CR) facilities should modulate their activities in view ongoing coronavirus disease 2019 (COVID-19) pandemic. A total number 150 statements were selected and graded Likert scale [from −5 (strongly disagree) to +5 agree)], starting six open-ended questions (i) referral criteria, (ii) optimal timing setting, (iii) core...
The aims of this paper were to provide an overview available activity monitors used in research patients with heart failure and identify the key criteria selection most appropriate monitor for collecting, reporting, analysing physical research. This study was conducted three parts. First, literature systematically reviewed concepts Second, additional scoping search validation these conducted. Third, identified. Nine evaluated terms size, weight, placement, costs, data storage, water...
Little is known either about physical activity patterns, or other lifestyle-related prevention measures in heart transplantation (HTx) recipients. The history of HTx started more than 50 years ago but there are still no guidelines position papers highlighting the features and rehabilitation after HTx. aims this scientific statement (i) to explain importance HTx, (ii) promote factors (modifiable/non-modifiable) that should be addressed improve patients' capacity, quality life survival. All...
Aim. To assess the changes of quality life (QoL) in patients after heart transplantation (HTx) and identifying factors associated with its changes. Material methods. We retrospectively assessed register created on basis original database "Mental status transplantation: experience Almazov National Medical Research Center" № 2023622138. There were following inclusion criteria: recipients aged over 18 years preserved cardiac transplant function (Simpson's left ventricular ejection fraction...
The article highlights the central components of Russian heart failure (HF) management programs in actual clinical practice. experience Competence Center Almazov National Medical Research Center, as well opportunities and prospects for improving monitoring decompensated HF.
Heart transplantation is a treatment of choice for patients with severe heart failure. Infection transmission from donor to recipient remains prominent problem in organ transplantation. However, the risk SARS-CoV-2 through nonlung still unclear. In article we present case 28-year-old pregnant woman who developed failure soon after recovery infection third trimester gestation. postpartum period disease worsened and patient required cardiac We examined recipient's diagnosed left...
Aim: to estimate physical capacity and quality of life (QoL) defi ne factors which impact on their dynamic in recipients after heart transplantation (HTx). Materials methods. From January 2010 September 2016 we performed 76 HTx (mean age – 45,4 ± 1,6 yrs). Physical activity (PA) was evaluated by IPAQ questionnaire, QoL SF-36 (6 months 1 yr HTx). Patients underwent cardiopulmonary exercise test (Oxycon Pro, Germany) before, 6 (n = 32) 31) HTx. Results. In PC improved (VO2peak 12,6 0,5 17,3...
Objective to estimate the frequency of dyslipidaemia (DLP) and determine risks after heart transplantation (HTx). Methods From 2010 2017 we performed 96 HTx (mean age 46,5±13,9 yrs; n=5 – children, 15 [10;16] yrs old). All patients were divided into 2 groups according causes failure: ischemic disease (IHD) (50%, n=48) others n=48). Before 36,5% (n=35) recipients had level cholesterol > 4,5 mmol/l. 56% (n=27) IHD underwent CABG or stent-implantation. coronary angiography (CAG) was in donors...
Aim. To compare the effect of nitric oxide (NO) and inhalatory iloprost (IIP) on hemodynamics pulmonary hypertension patients, associated with severe systolic dysfunction left ventricle (LV). Material methods . A retrospective description research performed, results 158 consequently done tests for reversibility NO IIP in 124 candidates cardiac transplantation, vascular resistance (PVR) more than 2,5 units Wood. Totally, 32 females 92 males investigated (mean age 48,9±11,2 y. o.) heart...
Patients after heart transplantation (HT) are at very high risk for cardiovascular disease. Protocols the management of recipients include initiation lipid-lowering therapy (LLT), regardless sex, age and origin failure. Given drug interactions post-transplant complications, LLT possibilities limited in transplanted population. The paper presents first Russian experience using siRNA treatment dyslipidemia solid organ transplant recipients.
Little is known either about physical activity patterns, or other lifestyle-related prevention measures in heart transplantation (HTx) recipients. The history of HTx started more than 50 years ago but there are still no guidelines position papers highlighting the features and rehabilitation after HTx. aims this scientific statement (i) to explain importance HTx, (ii) promote factors (modifiable/non-modifiable) that should be addressed improve patients' capacity, quality life survival. All...
Patients after heart transplantation (HT) have a high risk of infectious complications, including hospitalization and death due to SARS-CoV-2 infection. However, both patients with failure recipients often face vaccination refusal insufficient data on its safety in this population. Aim. To evaluate the efficacy against coronavirus disease 2019 (COVID-19) individuals HT. Material methods. This retrospective analysis multicenter registry created basis "Database depending COVID-19" (№...
Heart transplantation is a treatment of choice for patients with severe heart failure. Infection transmission from donor to recipient remains prominent problem in organ transplantation. However, the risk SARS-CoV-2 nonlung still unclear. In this article we presented case 28-year-old pregnant woman who developed failure soon after recovery infection third trimester gestation. postpartum period, disease worsened and patient required cardiac We examined recipient’s made diagnosis left...